Overview

Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

Status:
RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
To explore the efficacy of a single low dose of esketamine for patients with irritable bowel syndrome (IBS).
Phase:
NA
Details
Lead Sponsor:
Beijing Tiantan Hospital
Treatments:
Esketamine